Adiponectin: Protection of the endothelium

被引：74

作者：

Lam K.S.L. ^{[1
]}

Xu A. ^{[1
]}

机构：

[1] Department of Medicine, Research Centre of Heart, Brain, Hormone and Healthy Aging, University of Hong Kong, Pokfulam

来源：

Current Diabetes Reports | 2005年 / 5卷 / 4期

关键词：

Adiponectin Level; Serum Adiponectin; Arterioscler Thromb Vasc Biol; High Molecular Weight Adiponectin; High Molecular Weight Form;

D O I：

10.1007/s11892-005-0019-y

中图分类号：

学科分类号：

摘要：

Low levels of adiponectin, a fat-derived hormone, are found in coronary heart disease, type 2 diabetes, obesity, and other insulin-resistant states. Conversely, high adiponectin levels are predictive of reduced coronary risk in long-term epidemiologic studies. A close association between hypoadiponectinemia and endothelial dysfunction has also been demonstrated. The various mechanisms through which adiponectin may protect the endothelium, via its insulin-sensitizing, antiatherogenic, anti-inflammatory, and antioxidant properties, are reviewed. Copyright © 2005 by Current Science Inc.

引用

页码：254 / 259

页数：5

共 48 条

[1]

Rimm E.B., Stampfer M.J., Giovannucci E., Et al., Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men, Am. J. Epidmiol., 141, pp. 1127-1171, (1995)

[2]

Rexrode K.M., Carey V.J., Hennekens C.H., Et al., Abdominal adiposity and coronary heart disease in women, JAMA, 280, pp. 2284-2285, (1998)

[3]

Thomas G.N., Ho S.Y., Lam K.S.L., Et al., Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese, Obes. Res., 12, pp. 1805-1813, (2004)

[4]

Furukawa S., Fujita T., Shimabukuro M., Et al., Increased oxidative stress in obesity and its impact on metabolic syndrome, J. Clin. Invest., 14, pp. 1752-1761, (2004)

[5]

Kubota N., Terauchi Y., Yamauchi T., Et al., Disruption of adiponectin causes insulin resistance and neointimal formation, J. Biol. Chem., 277, pp. 25863-25866, (2002)

[6]

Matsuda M., Shimomura I., Sata M., Et al., Role of adiponectin in preventing vascular stenosis: The missing link of adipovascular axis, J. Biol. Chem., 277, pp. 37487-37491, (2002)

[7]

Yamauchi T., Kamon J., Waki H., Et al., Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis, J. Biol. Chem., 278, pp. 2461-2468, (2003)

[8]

Kumada M., Kihar S., Sumitsuji S., Et al., Association of hypoadiponectinemia with coronary artery disease in men, Arterioscler. Thromb. Vasc. Biol., 23, pp. 85-89, (2003)

[9]

Pischon T., Girman C.J., Hotamisligil G.S., Et al., Plasma adiponectin levels and risk of myocardial infarction in men, JAMA, 291, pp. 1730-1737, (2004)

[10]

Costacou T., Zgibor J.C., Evans R.W., Et al., The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study, Diabetologia, 48, pp. 41-48, (2005)

← 1 2 3 4 5 →